Microaxial LVAD market seen reaching $1.02 billion by 2030

The intravascular microaxial LVAD devices market is projected to nearly double from 2025 to 2030 as demand rises for minimally invasive cardiac support. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Intravascular microaxial LVAD devices provide temporary circulatory support for patients with severe heart failure and during high-risk cardiac procedures. - Rising demand for minimally invasive cardiac support is expanding the market for devices used as a bridge to recovery, transplant, or longer-term support. - The market is projected to reach $1.02 billion by 2030, signaling continued adoption across cardiac care settings.

What happened: - The Business Research Company released a 2026 report on the intravascular microaxial LVAD devices market, covering market size, trends, and forecasts through 2035. - The market is estimated at $0.45 billion in 2025 and is forecast to rise to $0.53 billion in 2026. - The report projects the market will grow at a 17.5% CAGR from 2025 to 2026 and at a 17.7% CAGR through 2030. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific is expected to be the fastest-growing region during the forecast period. - Download a free sample of the market report - View the full market report

The details: - Intravascular microaxial LVAD devices are minimally invasive mechanical circulatory support systems that help the left ventricle pump blood through the body. - The devices use a small axial flow pump inserted through blood vessels to maintain cardiac output during severe heart failure or high-risk cardiac procedures. - Temporary hemodynamic support from these devices can improve blood circulation and reduce strain on weakened hearts. - The report links market growth to more advanced heart failure cases, fewer donor hearts for transplantation, and wider use of temporary mechanical circulatory support. - Rising use of percutaneous coronary intervention procedures and expansion of cardiac catheterization lab infrastructure are also supporting demand. - The forecast period is expected to benefit from an aging population with cardiovascular disorders and advances in short-term ventricular assist technology. - The report highlights growing clinical preference for bridge-to-recovery therapies and expansion of specialized cardiac care centers worldwide. - Key trends identified include minimally invasive percutaneous ventricular support, hemocompatible blood pump materials, ultra-compact axial flow pumps, longer mechanical circulatory support duration, and catheter-based intervention workflows. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, and the Middle East and Africa.

Between the lines: - Cardiovascular disease is the clearest demand driver, with an aging population and more risk factors increasing the patient pool. - The report cites an American Heart Association figure showing the US age-adjusted cardiovascular disease death rate rose to 233.3 per 100,000 in January 2024, up 4.0% from 224.4 per 100,000 in 2023. - Higher healthcare spending is also helping hospitals adopt advanced cardiac care technologies. - The UK Office for National Statistics reported in May 2024 that total healthcare expenditure rose 5.6% in nominal terms from 2022 to 2023, after a 0.9% increase in 2022. - The regional split suggests mature demand in North America and faster expansion tied to broader access and infrastructure growth in Asia-Pacific.

What's next: - The market is expected to continue expanding as hospitals increase use of minimally invasive circulatory support options. - Future growth will likely track progress in compact pump design, hemocompatible materials, and longer-duration support capabilities. - Expansion of specialized cardiac care centers should widen access to these devices across more geographies. - The Business Research Company says its 2026 reports now add market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspot infographics, and updated graphics and tables.

The bottom line: - Intravascular microaxial LVAD devices are moving from a niche support tool toward a broader growth market, powered by rising cardiovascular disease, more cardiac procedures, and hospital investment in advanced care.